Sao Tome and Principe vs Western Pacific (WHO region): Previously treated cases tested for RR-/MDR-TB
Sao Tome and Principe
100.0%
in 2024
Western Pacific (WHO region)
86.0%
in 2024
Sao Tome and Principe rank
1st
Western Pacific (WHO region) rank
3rd
Previously treated cases tested for RR-/MDR-TB over time
- Sao Tome and Principe
- Western Pacific (WHO region)
How they compare
Sao Tome and Principe currently reports 100.0% against 86.0% in Western Pacific (WHO region), a difference of 14.0%.
That makes Sao Tome and Principe's figure about 1.2 times Western Pacific (WHO region)'s.
The two have swapped places 4 times across 14 shared years of data; in 2011 it was Sao Tome and Principe ahead.
Sao Tome and Principe ranks 1st and Western Pacific (WHO region) ranks 3rd of 180 countries.
Western Pacific (WHO region) has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Sao Tome and Principe | Western Pacific (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 27.7% | 60.7% | 33.0% | Western Pacific (WHO region) |
| 2020s | 60.0% | 89.2% | 29.2% | Western Pacific (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Sao Tome and Principe or Western Pacific (WHO region)?
- Sao Tome and Principe, at 100.0% against 86.0% in Western Pacific (WHO region) as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Sao Tome and Principe and Western Pacific (WHO region)?
- 14.0%, with Sao Tome and Principe ahead.
- How many years of comparable data are there for Sao Tome and Principe and Western Pacific (WHO region)?
- 14 years are reported by both, from 2011 to 2024.
- How do Sao Tome and Principe and Western Pacific (WHO region) rank globally for previously treated cases tested for rr-/mdr-tb?
- Sao Tome and Principe ranks 1st and Western Pacific (WHO region) ranks 3rd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.